Combined Use of Duloxetine and Olanzapine in the Treatment of Urologic Chronic Pelvic Pain Syndromes Refractory to Conventional Treatment: A Case Report
Clinical Psychopharmacology and Neuroscience
;
: 122-125, 2018.
Article
in English
| WPRIM
| ID: wpr-739451
ABSTRACT
Patients with urologic chronic pelvic pain syndromes (UCPPS) report interstitial cystitis/bladder pain syndrome and/or chronic prostatitis/chronic pelvic pain syndrome. The pathogenesis of these syndromes remains unclear and there is currently no standard treatment. UCPPS is, therefore, often misdiagnosed and its management is complex. The present case report involves a 62-year-old male patient with UCPPS whose main presentation is painful bladder filling and painful urgency refractory to conventional treatment with medication, which was successfully treated with the combined use of duloxetine and olanzapine. The combined use of duloxetine and olanzapine may become a new therapeutic option in the management of UCPPS.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Anxiety
/
Urinary Bladder
/
Pelvic Pain
/
Duloxetine Hydrochloride
Limits:
Humans
/
Male
Language:
English
Journal:
Clinical Psychopharmacology and Neuroscience
Year:
2018
Type:
Article
Similar
MEDLINE
...
LILACS
LIS